See All Slides - tctmd.com

Slides

Presentation TCT 2013

PCSK9 Inhibitors: Too Good to Be True?

Presenter: Evan Stein

October 30, 2013

Presentation TCT 2013

Atrial Septal Closure Devices: Choosing the Ideal Candidate for Transcatheter Closure

Presenter: Rebecca Hahn

October 30, 2013

Presentation TCT 2013

What Really Matters: Integrating Hard Endpoints (eg, Death, MI), Quality-of-Life Metrics, and Patient Preferences

Presenter: John Spertus

October 30, 2013

Presentation TCT 2013

Featured Trial of the Day: EUROMAX: A Prospective, Randomized Trial of Ambulance Initiation of Bivalirudin vs. Heparin ± Glycoprotein IIb/IIIa Inhibitors in Patients with STEMI...

Presenter: Philippe Gabriel Steg

October 30, 2013

Presentation TCT 2013

Early Human Clinical Studies in the US: Requirements, Challenges and Opportunities

Presenter: Andrew Farb

October 30, 2013

Presentation TCT 2013

How to Recognize Artifacts and Avoid Mistakes

Presenter: Soo-Jin Kang

October 30, 2013

Presentation TCT 2013

Fundamentals of IVUS Acquisition and Analysis

Presenter: Robert Russo

October 30, 2013

Presentation TCT 2013

The Great Debate: Does It Make Sense to Search and Destroy Focal Vulnerable Plaque? Yes! We Can Do This Safely, and It Will Save Lives and Prevent ACS!

Presenter: Patrick Serruys

October 30, 2013

Presentation TCT 2013

The Case for Intravenous Cangrelor as the Preferred ADP Antagonist to Support Primary PCI

Presenter: Deepak Bhatt

October 30, 2013

Presentation TCT 2013

International MitraClip Commercial Experience

Presenter: Corrado Tamburino

October 30, 2013

Advertisement

Slides

PCSK9 Inhibitors: Too Good to Be True?

Atrial Septal Closure Devices: Choosing the Ideal Candidate for Transcatheter Closure

What Really Matters: Integrating Hard Endpoints (eg, Death, MI), Quality-of-Life Metrics, and Patient Preferences

Featured Trial of the Day: EUROMAX: A Prospective, Randomized Trial of Ambulance Initiation of Bivalirudin vs. Heparin ± Glycoprotein IIb/IIIa Inhibitors in Patients with STEMI...

Early Human Clinical Studies in the US: Requirements, Challenges and Opportunities

How to Recognize Artifacts and Avoid Mistakes

Fundamentals of IVUS Acquisition and Analysis

The Great Debate: Does It Make Sense to Search and Destroy Focal Vulnerable Plaque? Yes! We Can Do This Safely, and It Will Save Lives and Prevent ACS!

The Case for Intravenous Cangrelor as the Preferred ADP Antagonist to Support Primary PCI

International MitraClip Commercial Experience

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content